Accordingly, several studies demonstrated that JNK pathway over-activation is crucial to the different forms of hepatocyte apoptosis, including the forms induced by chronic and acute stress from ROS [46, 47]. Therefore, we conclude that the generation of ROS also contributes to JNK activation following DHA Caspase Inhibitor VI treatment.
The resolution of the function of JNK in autophagy regulation is imminent. It was observed that autophagy associated with endoplasmic reticulum stress (ERS) was inhibited in IRE1-deficient cells or in cells treated with a JNK inhibitor, suggesting that IRE1-JNK is required for ERS-induced autophagy [32]. These data suggest that JNK may play a crucial role in autophagy. In this study, we showed that DHA activated the JNK pathway and mediated autophagy. We showed that DHA increased JNK phosphorylation in pancreatic cancer cells in a time- and dose-dependent manner. Activation of the JNK learn more pathway results in Bcl-2 phosphorylation, an event known to enhance autophagy by disrupting the Bcl-2/Beclin 1 competitive interaction [33]. Bcl-2 is able to regulate Beclin 1-induced autophagy by directly
binding to Beclin 1, and thus preventing its activation [48]. Similarly, we observed that JNK was involved in Beclin 1 expression, which then played a crucial role in protective autophagy in DHA-induced cancer cells. Although, Beclin 1 up-regulation by JNK was observed after autophagy induced by the anticancer drug topotecan, the data presented in the present study constitute the first evidence that Beclin 1 is Epothilone B (EPO906, Patupilone) regulated by JNK in pancreatic cancer cells. Conclusions Our results suggest that autophagy was induced by DHA in the studied human pancreatic cancer cell lines. DHA also activated JNK, thus up-regulating Beclin 1. JNK activation primarily depends on ROS, which is generated by DHA treatment. Moreover,
inhibiting the JNK pathway and silencing Beclin 1 expression could inhibit DHA-induced autophagy. These results suggest that autophagy can be induced by DHA through Beclin 1 expression induced by JNK. Silencing of JNK kinase may constitute appealing therapeutic target for a generalized strategy to treat cancer through blunting of autophagy. This may support a novel therapeutic strategy against pancreatic cancer in clinical settings. Acknowledgements The authors thank Dr. Noboru Mizushima for providing the LC3 cDNA. This work was supported by the National Natural Scientific Foundation of China (81170431), the China Postdoctoral Science Foundation (20110491109) and the China Postdoctoral Science special Foundation (2012 T50374). GSK461364 mw References 1. Deng R, Li W, Guan Z, Zhou JM, Wang Y, Mei YP, Li MT, Feng GK, Huang W, Liu ZC, Han Y, Zeng YX, Zhu XF: Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Oncogene 2006, 25:7070–7077.PubMedCrossRef 2.